Nicholas C. DeVito

1.3k total citations · 1 hit paper
31 papers, 935 citations indexed

About

Nicholas C. DeVito is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Nicholas C. DeVito has authored 31 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Nicholas C. DeVito's work include Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (7 papers). Nicholas C. DeVito is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (7 papers). Nicholas C. DeVito collaborates with scholars based in United States, Singapore and India. Nicholas C. DeVito's co-authors include Brent A. Hanks, Alisha Holtzhausen, Michael P. Plebanek, Kathy S. Evans, Christine Xiao, Fei Zhao, April K.S. Salama, Balamayooran Theivanthiran, Xiaojing Liu and Juan Liu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nicholas C. DeVito

29 papers receiving 924 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

2024 59 citations Michael P. Plebanek, Yue Xue et al. Science Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas C. DeVito United States	13	487	457	374	173	123	31	935
Mary Litzinger United States	13	582 1.2×	721 1.6×	454 1.2×	189 1.1×	288 2.3×	15	1.3k
Osama Al‐Assar United Kingdom	11	187 0.4×	464 1.0×	256 0.7×	139 0.8×	57 0.5×	17	694
Amanda R. Dancsok Canada	6	251 0.5×	331 0.7×	204 0.5×	77 0.4×	261 2.1×	6	659
Dali Huang United States	13	175 0.4×	185 0.4×	283 0.8×	119 0.7×	268 2.2×	18	777
Badreddin Edris United States	11	311 0.6×	318 0.7×	390 1.0×	269 1.6×	259 2.1×	17	951
Zhangyan Guo China	13	269 0.6×	312 0.7×	441 1.2×	317 1.8×	119 1.0×	18	917
Laura Botti Italy	14	288 0.6×	247 0.5×	331 0.9×	210 1.2×	78 0.6×	23	716
Sophia Bornstein United States	9	275 0.6×	433 0.9×	441 1.2×	166 1.0×	93 0.8×	17	819
Marina Gualco Italy	14	354 0.7×	335 0.7×	221 0.6×	56 0.3×	65 0.5×	26	697
Naiara Perurena United States	10	631 1.3×	359 0.8×	337 0.9×	143 0.8×	153 1.2×	15	1.1k

Countries citing papers authored by Nicholas C. DeVito

Since Specialization

Citations

This map shows the geographic impact of Nicholas C. DeVito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas C. DeVito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas C. DeVito more than expected).

Fields of papers citing papers by Nicholas C. DeVito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas C. DeVito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas C. DeVito. The network helps show where Nicholas C. DeVito may publish in the future.

Co-authorship network of co-authors of Nicholas C. DeVito

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas C. DeVito. A scholar is included among the top collaborators of Nicholas C. DeVito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas C. DeVito. Nicholas C. DeVito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeVito, Nicholas C., Michael P. Plebanek, Nagendra Sastry Yarla, et al.. (2025). GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling. Cancer Research. 85(9). 1644–1662. 1 indexed citations

Hecht, J. Randolph, Diwakar Davar, Marwan Fakih, et al.. (2025). Phase 1/2 study of XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, in combination with atezolizumab in patients with advanced solid tumors and in MSS CRC.. Journal of Clinical Oncology. 43(4_suppl). 206–206. 1 indexed citations

Plebanek, Michael P., Yue Xue, Nicholas C. DeVito, et al.. (2024). A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Science Immunology. 9(95). eadi4191–eadi4191. 59 indexed citations breakdown →

DeVito, Nicholas C., et al.. (2023). Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment Response. Cancers. 15(17). 4347–4347. 5 indexed citations

Blobe, Gerard C., Nicholas C. DeVito, Brent A. Hanks, et al.. (2023). Assessing the utility of molecular diagnostic classification for cancers of unknown primary. Cancer Medicine. 12(19). 19394–19405. 2 indexed citations

Theivanthiran, Balamayooran, Tarek Haykal, Michelle Ferreira, et al.. (2022). Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy. Science Translational Medicine. 14(672). eabq7019–eabq7019. 34 indexed citations

DeVito, Nicholas C., et al.. (2022). Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use. Journal of Medical Economics. 25(1). 817–825. 2 indexed citations

Al‐Rohil, Rami N., Tarek Haykal, April K.S. Salama, et al.. (2022). Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events. Journal of Immunotherapy. 45(6). 284–290.

DeVito, Nicholas C., Christine Xiao, Michael P. Plebanek, et al.. (2021). Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy. Cell Reports. 35(5). 109071–109071. 57 indexed citations

10.

DeVito, Nicholas C., Kyle C. Strickland, James L. Abbruzzese, et al.. (2021). A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis. AME Case Reports. 5. 14–14. 1 indexed citations

11.

Theivanthiran, Balamayooran, Tarek Haykal, Alisha Holtzhausen, et al.. (2021). Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers. 13(19). 4753–4753. 13 indexed citations

12.

Sammons, Sarah, Andrew Elliott, Jeremy Force, et al.. (2021). Genomic evaluation of tumor mutational burden-high (TMB-H) versus TMB-low (TMB-L) metastatic breast cancer to reveal unique mutational features.. Journal of Clinical Oncology. 39(15_suppl). 1091–1091. 4 indexed citations

13.

Evans, Kathy S., Nicholas C. DeVito, Michael P. Plebanek, et al.. (2020). A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy. Journal of Clinical Investigation. 130(5). 2570–2586. 187 indexed citations

14.

DeVito, Nicholas C., et al.. (2019). Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion. Frontiers in Immunology. 10. 2876–2876. 79 indexed citations

15.

Zhao, Fei, Kathy S. Evans, Christine Xiao, et al.. (2018). Stromal Fibroblasts Mediate Anti–PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma. Cancer Immunology Research. 6(12). 1459–1471. 91 indexed citations

16.

Zhao, Fei, Christine Xiao, Kathy S. Evans, et al.. (2018). Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization. Immunity. 48(1). 147–160.e7. 215 indexed citations

17.

DeVito, Nicholas C., Gang Han, Damon R. Reed, et al.. (2015). Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience. PLoS ONE. 10(10). e0140362–e0140362. 64 indexed citations

18.

DeVito, Nicholas C., et al.. (2014). Small Lymphocytic Lymphoma Presenting As a Paraneoplastic Syndrome With Acute Central Nervous System Demyelination. Clinical Lymphoma Myeloma & Leukemia. 14(4). e131–e135. 2 indexed citations

19.

DeVito, Nicholas C., Martin Goodman, Daniel A. Popowich, et al.. (2014). A pilot study evaluating the safety and impact of pretreatment with metformin on colorectal cancer stem cells (CCSC) in patients undergoing resection.. Journal of Clinical Oncology. 32(15_suppl). e14581–e14581. 4 indexed citations

20.

Assudani, Deepak, et al.. (2008). In vivo Expansion, Persistence, and Function of Peptide Vaccine–Induced CD8 T Cells Occur Independently of CD4 T Cells. Cancer Research. 68(23). 9892–9899. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact